Institutional Ownership Ultragenyx Pharmaceutical Inc. (RARE)
This table provides information about the institutional ownership of Ultragenyx Pharmaceutical Inc. (RARE). We have compiled data on the 287 institutions that hold shares in the stock, with a total of 88.1 Million shares, which have been reported (via 13F filing form) to have a value of $4.86 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Bio Impact Capital LLC
Cambridge, MA |
Aug 14, 2024 Q2 2024 |
380,552
shares
|
$20.7 Million
2.51% of portfolio
|
Q2 2024
Added 54.95%
|
|
|
Massachusetts Financial Services CO
Boston, MA |
Aug 09, 2024 Q2 2024 |
370,247
shares
|
$20.2 Million
0.0% of portfolio
|
Q2 2024
Added 38.69%
|
|
|
Cutter Capital Management, LP
New York, NY |
Aug 14, 2024 Q2 2024 |
365,000
shares
|
$19.9 Million
4.53% of portfolio
|
Q2 2024
New holding
|
|
|
Schroder Investment Management Group
London, X0 |
Aug 12, 2024 Q2 2024 |
357,438
shares
|
$19.5 Million
0.02% of portfolio
|
Q2 2024
Added 40.13%
|
|
|
Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main
Frankfurt Am Main, 2M |
Aug 14, 2024 Q2 2024 |
294,723
shares
|
$16 Million
0.01% of portfolio
|
Q2 2024
Added 87.39%
|
|
|
Franklin Resources Inc
San Mateo, CA |
Aug 14, 2024 Q2 2024 |
293,894
shares
|
$16 Million
0.0% of portfolio
|
Q2 2024
Added 36.11%
|
|
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
Aug 14, 2024 Q2 2024 |
293,832
shares
|
$16 Million
1.77% of portfolio
|
Q2 2024
Added 23.18%
|
|
|
Abrdn PLC
|
Aug 09, 2024 Q2 2024 |
284,745
shares
|
$15.5 Million
0.02% of portfolio
|
Q2 2024
Added 101.78%
|
|
|
First Trust Advisors LP
Wheaton, IL |
Aug 13, 2024 Q2 2024 |
281,093
shares
|
$15.3 Million
0.01% of portfolio
|
Q2 2024
Reduced 23.66%
|
|
|
Artal Group S.A.
Luxembourg, N4 |
Aug 14, 2024 Q2 2024 |
275,000
shares
|
$15 Million
0.72% of portfolio
|
Q2 2024
Added 54.55%
|
|
|
Blue Owl Capital Holdings LP
New York, NY |
Aug 15, 2024 Q2 2024 |
268,238
shares
|
$14.6 Million
4.58% of portfolio
|
Q1 2024
Added 1.9%
|
|
|
Woodline Partners LP
San Francisco, CA |
Aug 14, 2024 Q2 2024 |
266,790
shares
|
$14.5 Million
0.11% of portfolio
|
Q2 2024
Reduced 33.32%
|
|
|
Privium Fund Management B.V.
|
Jul 31, 2024 Q2 2024 |
251,602
shares
|
$13.7 Million
2.92% of portfolio
|
Q2 2024
Added 16.97%
|
|
|
International Biotechnology Trust PLC
London, X0 |
Nov 14, 2023 Q3 2023 |
250,052
shares
|
$13.6 Million
3.03% of portfolio
|
Q3 2023
Added 212.36%
|
|
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
Aug 14, 2024 Q2 2024 |
247,138
shares
|
$13.5 Million
0.01% of portfolio
|
Q2 2024
Reduced 14.04%
|
|
|
Moore Capital Management, LP
New York, NY |
Aug 14, 2024 Q2 2024 |
245,000
shares
|
$13.3 Million
0.19% of portfolio
|
Q2 2024
Added 32.43%
|
|
|
Macquarie Group LTD
Australia, C3 |
Aug 09, 2024 Q2 2024 |
229,482
shares
|
$12.5 Million
0.01% of portfolio
|
Q2 2024
Added 4.16%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Aug 12, 2024 Q2 2024 |
221,025
shares
|
$12 Million
0.0% of portfolio
|
Q2 2024
Reduced 12.35%
|
|
|
Chi Advisors LLC
New York, NY |
Nov 13, 2023 Q3 2023 |
215,000
shares
|
$11.7 Million
3.78% of portfolio
|
Q3 2023
Added 152.94%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Aug 09, 2024 Q2 2024 |
204,223
shares
|
$11.1 Million
0.0% of portfolio
|
Q2 2024
Reduced 43.8%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Aug 14, 2024 Q2 2024 |
203,442
shares
|
$11.1 Million
0.01% of portfolio
|
Q2 2024
New holding
|
|
|
Credit Suisse Ag
Zurich, V8 |
May 10, 2024 Q1 2024 |
201,268
shares
|
$11 Million
0.01% of portfolio
|
Q1 2024
Reduced 7.67%
|
|
|
Ubs Group Ag
|
Aug 13, 2024 Q2 2024 |
195,891
shares
|
$10.7 Million
0.0% of portfolio
|
Q2 2024
Added 15.8%
|
|
|
Jane Street Group, LLC
New York, NY |
Aug 14, 2024 Q2 2024 |
185,061
shares
|
$10.1 Million
0.01% of portfolio
|
Q2 2024
Added 182.8%
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Aug 13, 2024 Q2 2024 |
176,809
shares
|
$9.62 Million
0.0% of portfolio
|
Q2 2024
Added 35.74%
|